Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.5 - $125.08 $19,700 - $25,016
200 New
200 $21,000
Q4 2022

Jan 31, 2023

SELL
$118.43 - $186.05 $12,198 - $19,163
-103 Reduced 33.99%
200 $30,000
Q3 2022

Oct 28, 2022

BUY
$127.65 - $183.11 $382 - $549
3 Added 1.0%
303 $41,000
Q1 2022

May 05, 2022

SELL
$126.25 - $231.85 $6,312 - $11,592
-50 Reduced 14.29%
300 $51,000
Q2 2020

Jul 30, 2020

BUY
$38.58 - $66.74 $5,787 - $10,011
150 Added 75.0%
350 $23,000
Q1 2020

Apr 30, 2020

BUY
$28.55 - $92.0 $5,710 - $18,400
200 New
200 $12,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Community Bank, N.A. Portfolio

Follow Community Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.